Jagsonpal Pharmaceuticals stock | Growth outlook for 2026 & price target

Jagsonpal Pharmaceut...

NSEI:JAGSNPHARM

Rp 184,69

+ Rp0,34 (0,18%)

184,69 Rp

+Rp0,34 (0,18%)

End-of-day quote: 03/30/2026

Jagsonpal Pharmaceuticals Stock Value

The current analyst rating for NSEI:JAGSNPHARM is sf_Data Unavailable.

Jagsonpal Pharmaceuticals Company Info

EPS Growth 5Y

0,00%

Market Cap

Rp12,34 B

Long-Term Debt

Rp0,00 B

Annual earnings

05/06/2026 (E)

Dividend

Rp2,49

Dividend Yield

1,35%

Founded

1978

Industry

Materials

Country

India

Website

Jagsonpal Pharmaceuticals

ISIN Number

INE048B01035

Website

http://www.jagsonpal.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Jagsonpal Pharmaceuticals’s Price Target has risen from Rp0,00 to Rp184,69 - a 100,00% increase.

Top growth stocks in the materials sector (5Y.)

What does Jagsonpal Pharmaceuticals do?

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients. Business Segments The company has established its operations across various segments within the pharmaceutical industry. The focus lies predominantly in the marketing and distribution sector, enabling the company to connect with healthcare professionals and understand the evolving demands of the market. The company occupied a vital space in prov...

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients.

Business Segments

The company has established its operations across various segments within the pharmaceutical industry. The focus lies predominantly in the marketing and distribution sector, enabling the company to connect with healthcare professionals and understand the evolving demands of the market. The company occupied a vital space in providing pharmaceutical products that cater to various medical needs, ensuring that diverse therapeutic options are available to healthcare practitioners.

Business Strategy

The company's business strategy is anchored in a multi-faceted approach for fostering growth, enhancing market penetration, and ensuring patient safety. The company emphasizes the importance of maintaining a strong product portfolio while continually exploring new opportunities within the pharmaceutical landscape.

Products and Services

The company offers a broad range of pharmaceutical products categorized under different therapeutic segments. The line-up includes prescription drugs spanning multiple therapeutic areas, including analgesics, antibiotics, and medications targeting specific health conditions. The company ensures that its products adhere to the highest quality standards throughout the lifecycle, from formulation to final distribution.

Key to the company’s success is its strategic collaboration with reputable contract manufacturers that allow it to leverage advanced technologies and expertise in drug formulation. This partnership model enables the company to maintain an expansive and diverse portfolio, catering to the evolving medical needs of both healthcare professionals and patients.

In addition to its products, the company offers extensive support services to healthcare professionals, ensuring that information on dosage, side effects, and contraindication is readily available. The educational initiatives, including webinars and seminars, sustain the company's relationship with stakeholders in the healthcare sector, enhancing overall brand trust and loyalty.

Geographical Markets

The company primarily serves the Indian pharmaceutical market, focusing on both urban and rural regions. The company strives to ensure that its offerings are accessible to healthcare providers across various healthcare settings, ensuring equitable healthcare access.

Customers

The company serves a myriad of customers within the healthcare sector, including hospitals, clinics, pharmacies, and individual healthcare professionals. This diverse customer base underscores the company's significant role in the pharmaceutical supply chain.

Sales and Marketing

The company employs a multi-channel approach to its sales and marketing efforts. This includes traditional direct sales teams, digital marketing initiatives, and active participation in industry conferences and seminars. The sales representatives are equipped with the necessary tools, such as visual aids-alongside educational programs to communicate effectively with healthcare professionals about the products offered. The distribution strategy is characterized by partnerships with third-party logistics providers, facilitating efficient delivery to various healthcare facilities.

History

Jagsonpal Pharmaceuticals Limited was founded in 1978. The company was incorporated in 1978.

New support ticket

Explore

Jagsonpal Pharmaceuticals Stock Value

Jagsonpal Pharmaceuticals Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Jagsonpal Pharmaceuticals do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Jagsonpal Pharmaceuticals Stock Value

Jagsonpal Pharmaceuticals Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Jagsonpal Pharmaceuticals do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.